Summary
The majority of all febrile seizures represent a benign syndrome that does not require extensive testing or long term medication. A careful history of the febrile seizure, family history, developmental history and physical examination can identify those infants and children with this syndrome. While one-third of this group will experience additional febrile seizures, there is no significant increase in the incidence of later epilepsy or neurological sequelae. The parents of these children need to be reassured and educated about this syndrome. They should understand the emergency treatment of seizures and aggressively treat fever.
The more difficult task for the physician is to correctly identify those children who experience nonbenign seizures. Careful history and physical examination can accurately identify this group. Further evaluation including neuroimaging, electroencephalogram and developmental assessment may be necessary. In those children with a high risk of later epilepsy, treatment with an antiepileptic drug should be considered.
Similar content being viewed by others
References
Adams F (Ed.) Prognostics 24. In The genuine works of Hippocrates, William Wood & Co., New York, 1929
Aicardi J, Chevrie JJ. Convulsive status epilepticus in infants and children: a study of 239 cases. Epilepsia 11: 187–197, 1970
Annegers JF, Hauser WA, Elveback LR. The risk of epilepsy following febrile convulsion. Neurology 29: 297–303, 1979
Annegers JF, Hauser WA, Shirts SB. Factors prognostic of unprovoked seizure after febrile convulsion. New England Journal of Medicine 316: 493–498, 1987
Burnham M. Anticonvulsants and the kindling model: a critical analysis. In Morrell F (Ed.) Kindling and synaptic plasticity, pp. 273–288, Birkhauser, Boston, 1991
Chevrie JJ, Aicardi J. Duration and lateralization of febrile convulsions: etiological factors. Epilepsia 16: 781–789, 1975
Consensus Development Conference on Febrile Seizures. Proceedings. Epilepsia 2: 377–381, 1981
Dingeldine R, McBain CJ, McNamara JO. Excitatory amino acid receptors in epilepsy. Trends in Pharmaceutical Science 11: 334–338, 1990
Doose H, Ritter K, Volzke E. EEG longitudinal study in febrile convulsions. Genetic Aspects of Neuropediatrics 14: 81–87, 1983
Driefuss FE, Langer H, Moline KA. Valproic acid hepatic fatalities: US experience since 1984. Neurology 39: 201–207, 1989
Ellenberg JH, Nelson KB. Febrile seizures and later intellectual performance. Archives of Neurology 35: 17–21, 1978
Falconer MA. Genetic and related aetiological factors in temporal lobe epilepsy: a review. Epilepsia 12: 13–31, 1971
Farwell JR, Lee YJ, Hirtz G. Phenobarbital for febrile seizures: effect on intelligence and on seizure reoccurrence. New England Journal of Medicine 322: 364–369, 1990
Faerø O, Kastrup KW, Nielsen EL, Melchior JC, Thorn I. Successful prophylaxis of febrile convulsions with phenobarbital. Epilepsia 13: 279–285, 1972
Frantzen E, Lennox-Buchthal M, Nygaard A. A genetic study of febrile convulsions. Neurology 20: 909–917, 1970
Fukuyama YK, Kawaga K, Tanaka KA. A genetic study of febrile convulsions. European Neurology 18: 166–182, 1979
Gastaut H. On genetic transmission of epilepsies. Epilepsia 10: 3–6, 1969
Geinisman Y, deToledo-Morrell L, Morrell F. Structural synaptic substrates of kindling and long term potentiation. In Morrell F (Ed.) Kindling and synaptic plasticity: the legacy of Graham God-dard, pp. 124–159, Birkhauser Press, Boston, 1991
Hauser WA, Annegers JF, Anderson VE. The risk of seizure disorder among relatives of children with febrile seizures. Neurology 35: 1268–1273, 1985
Hirtz G, Nelson KB, Ellenberg JH. Seizures following childhood immunizations. Journal of Pediatrics 102: 14–18, 1983
Jaffe M, Bar-Joseph G, Tirosh E. Fever and convulsions: indications for laboratory investigation. Pediatrics 67: 729–782, 1981
Knudsen FU. Effective short-term diazepam prophylaxis in febrile convulsions. Journal of Pediatrics 106: 487–490, 1985
Knudsen FU, Vestermark S. Prophylactic diazepam or phenobarbi-tone in febrile convulsions: a prospective controlled study. Archives of Disease in Childhood 53: 660–663, 1978
Lahat E, Katz Y, Bistritzer T. Recurrent seizures in children with Shigella-associated convulsions. Annals of Neurology 28: 393–395, 1990
Lennox-Buchthal MA. Febrile Convulsions. In Magnus & DeHaas (Eds) The Epilepsies, pp. 246–262, American Elsevier Publishing Co., New York, 1974
Livingston S. Comprehensive management of epilepsy in infancy, childhood and adolescence. Charles C. Thomas Publisher, Springfield, 1972
Maytal J, Shinnar S. Febrile status epilepticus. Pediatrics 86: 611–616, 1990
Maytal J, Shinnar S, Moshé SL. Low morbidity and mortality of status epilepticus in children. Pediatrics 83: 323–331, 1989
McDonald JW, Johnston MV. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Research Reviews 15: 41–70, 1990
McNamara JO. Role of neurotransmitters in seizure mechanisms in the kindling model of epilepsy. FASEB Journal 43: 2516–2520, 1984
McNamara JO, Byrne MC, Dasheiff RM. The kindling model of epilepsy: a review. Progress in Neurobiology 15: 139–159, 1980
Melchior JC, Buchthal F, Lennox-Buchthal M. The ineffectiveness of diphenylhydantoin in preventing febrile convulsions in the age of greatest risk, under three years. Epilepsia 12: 55–62, 1971
Meldrum BS. Cell damage in epilepsy and the role of calcium in cytotoxicity. Advances in Neurology 44: 275–299, 1986
Mullicap JG, Aledort LM, Madsen JA. A critical evaluation of therapy of febrile seizures. Journal of Pediatrics 56: 364–368, 1960
Nelson KB, Ellenberg JH. Predictors of epilepsy in children who have experienced febrile seizures. New England Journal of Medicine 295: 1029–1033, 1976
Nelson KB, Ellenberg JH. Prognosis in children with febrile seizures. Pediatrics 61: 720–727, 1978
Ngwane E, Bower B. Continuous sodium valproate or phenobarbi-tone in the prevention of ‘simple’ febrile convulsions. Archives of Disease in Childhood 55: 171–174, 1980
Penfield W, Jasper H. Epilepsy and the functional anatomy of the human brain, pp. 281–349, Little Brown and Company, Boston, 1954
Ross EM, Peckham CS, West PB. Epilepsy in childhood: findings from the National Child Development Study. British Medical Journal 280: 207–210, 1980
Rothman SM, Olney JW. Excitotoxicity and the NMA receptor. Trends in Neurosciences 10: 299–302, 1987
Sahib El-Radhi AS, Withawa K, Banajeh S. Reoccurrence rate of febrile convulsion related to the degree of pyrexia during the first attack. Clinical Pediatrics 25: 311–313, 1986
Silver JM, Shin C, McNamara JO. Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Annals of Neurology 29: 356–363, 1991
Svensmark O, Buchthal F. Accumulation of phenobarbital in man. Epilepsia 4: 199–206, 1963
Taylor DC, Ounsted C. Biological mechanisms influencing the outcome of seizures in response to fever. Epilepsia 12: 33–45, 1971
Trimble MR, Thompson PJ. Sodium valproate and cognitive function. Epilepsia 25(Suppl.): 60–64, 1984
Tsuboi T. Genetic aspects of febrile convulsions. Human Genetics 38: 169–173, 1977
Verity CM, Butler NR, Golding J. Febrile convulsions in a national cohort followed from birth: prevalence and reoccurrence in the first five years of life. British Medical Journal 116: 329–337, 1985
Wallace SJ. Spontaneous fits after convulsions with fever. Archives of Disease in Childhood 52: 192–196, 1977
Wallace SJ, Smith J. Successful prophylaxis against febrile convulsions with valproic acid or phenobarbitone. British Medical Journal 280: 353–354, 1980
Wolf SM, Forsythe A, Stunden AA. Long-term effect of phenobarbital on cognitive function in children with febrile convulsions. Pediatrics 68: 820–823, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smith, M.C. Febrile Seizures. Drugs 47, 933–944 (1994). https://doi.org/10.2165/00003495-199447060-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199447060-00006